• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors.

作者信息

Breu V, Löffler B M, Clozel M

机构信息

Pharma Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

出版信息

FEBS Lett. 1993 Nov 15;334(2):210-4. doi: 10.1016/0014-5793(93)81713-a.

DOI:10.1016/0014-5793(93)81713-a
PMID:8224248
Abstract

Ro 46-2005 is a new synthetic non-peptide endothelin (ET) receptor antagonist. In binding experiments, Ro 46-2005 proved to be equipotent (IC50 200-500 nM) for inhibition of [125]ET-1 binding on the two known ET receptor subtypes (ETA and ETB). Scatchard analysis was consistent with a competitive binding mode. Ro 46-2005 also inhibited the functional consequences of ET-1 stimulation: the ET-1 induced release of arachidonic acid from rat mesangial cells was inhibited with an IC50 of 1.8 microM.

摘要

相似文献

1
In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors.
FEBS Lett. 1993 Nov 15;334(2):210-4. doi: 10.1016/0014-5793(93)81713-a.
2
In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.一种对ETA受体具有选择性的高效新型内皮素（ET）拮抗剂BQ-123的体外生物学特性
J Cardiovasc Pharmacol. 1992;20 Suppl 12:S11-4. doi: 10.1097/00005344-199204002-00005.
3
In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ETB receptor.
FEBS Lett. 1996 Mar 25;383(1-2):37-41. doi: 10.1016/0014-5793(96)00213-x.
4
BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
J Pharmacol Exp Ther. 1995 Mar;272(3):1124-34.
5
Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites.系膜细胞中内皮素受体的特性：存在两种功能不同的内皮素结合位点的证据。
Mol Pharmacol. 1994 Jul;46(1):41-50.
6
Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.内皮素-1（ET-1）诱导大鼠离体气管收缩：ETA和ETB受体及多种信号转导系统的参与
Br J Pharmacol. 1993 Sep;110(1):435-41. doi: 10.1111/j.1476-5381.1993.tb13829.x.
7
Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist.内皮素受体拮抗剂与激动剂孵育后，其效力会逐渐减弱。
Life Sci. 1994;54(22):1727-34. doi: 10.1016/0024-3205(94)00613-x.
8
Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.利用人克隆的ETA和ETB受体对三种非肽类内皮素受体配体进行表征。
Br J Pharmacol. 1994 Aug;112(4):1251-7. doi: 10.1111/j.1476-5381.1994.tb13218.x.
9
Endothelin receptors in human smooth muscle cells: antagonist potency differs on agonist-evoked responses.
Am J Physiol. 1994 Nov;267(5 Pt 1):C1185-95. doi: 10.1152/ajpcell.1994.267.5.C1185.
10
Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.大鼠和人原代培养气道平滑肌细胞中内皮素受体介导的Ca2+信号转导
Br J Pharmacol. 1998 Dec;125(8):1768-78. doi: 10.1038/sj.bjp.0702252.

引用本文的文献

1
The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction.在颗粒物诱导的心脏功能障碍中，心脏作为内皮素-1的血管外靶点。
Pharmacol Ther. 2016 Sep;165:63-78. doi: 10.1016/j.pharmthera.2016.05.006. Epub 2016 May 21.
2
[D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.[D-缬氨酸22]大内皮素-1[16-38]抑制内皮素转化酶活性：预防脑血管痉挛的一个有前景的概念。
Neurosurg Rev. 2003 May;26(2):125-32. doi: 10.1007/s10143-002-0242-9. Epub 2002 Nov 19.
3
Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
[125I] -内皮素-1和[125I] -BQ3020与大鼠小脑内皮素受体结合的特性研究
Br J Pharmacol. 1996 Aug;118(8):2126-30. doi: 10.1111/j.1476-5381.1996.tb15652.x.
4
Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease.内皮素与内皮素拮抗剂：在心血管疾病和肾脏疾病中的潜在作用。
Mol Cell Biochem. 1996;157(1-2):259-67. doi: 10.1007/BF00227908.
5
Endothelins. A potential target for pharmacological intervention in diseases of the elderly.
Drugs Aging. 1994 Mar;4(3):221-37. doi: 10.2165/00002512-199404030-00005.
6
Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.利用人克隆的ETA和ETB受体对三种非肽类内皮素受体配体进行表征。
Br J Pharmacol. 1994 Aug;112(4):1251-7. doi: 10.1111/j.1476-5381.1994.tb13218.x.